Rescue therapy for Helicobacter pylori infection 2012

Gastroenterology Research and Practice

Volumn , Issue , 2012, Pages

  Gisbert, Javier P ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; LEVOFLOXACIN; METRONIDAZOLE; NITROIMIDAZOLE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; RIFABUTIN; TETRACYCLINE; TINIDAZOLE;

DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERADICATION THERAPY; GASTRITIS; GASTRODUODENAL ULCER; GASTROINTESTINAL SYMPTOM; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; LEUKOPENIA; LOW DRUG DOSE; NONHUMAN; REVIEW; STOMACH CANCER; TENDINITIS; TENDON RUPTURE; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 84858329429     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2012/974594     Document Type: Review

References (159)

1. Vakil N., H. pylori treatment: new wine in old bottles American Journal of Gastroenterology 2009 104 1 26 30
2. Gisbert J. P., Calvet X., O'Connor A., Mégraud F., O'Morain C. A., Sequential therapy for Helicobacter pylori eradication: a critical review Journal of Clinical Gastroenterology 2010 44 5 313 325
3. Gisbert J. P., Calvet X., Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobater pylori Alimentary Pharmacology and Therapeutics 2011 34 6 604 617
4. Howden C. W., Hunt R. H., Guidelines for the management of Helicobacter pylori infection American Journal of Gastroenterology 1998 93 12 2330 2338 (Pubitemid 29018534)
5. Malfertheiner P., Mégraud F., O'Morain C., Hungin A. P.S., Jones R., Axon A., Graham D. Y., Tytgat G., Current concepts in the management of Helicobacter pylori infectionthe Maastricht 2-2000 Consensus Report Alimentary Pharmacology and Therapeutics 2002 16 2 167 180 (Pubitemid 34146357)
6. Malfertheiner P., Megraud F., O'Morain C., Bazzoli F., El-Omar E., Graham D., Hunt R., Rokkas T., Vakil N., Kuipers E. J., Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report Gut 2007 56 6 772 781 (Pubitemid 46854190)
7. Selgrad M., Bornschein J., Malfertheiner P., Guidelines for treatment of Helicobacter pylori in the East and West Expert Review of Anti-Infective Therapy 2011 9 8 581 588
8. Gisbert J. P., Gonzlez L., Calvet X., Garca N., Lpez T., Roqué M., Gabriel R., Pajares J. M., Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole: a meta-analysis of eradication of Helicobacter pylori Alimentary Pharmacology and Therapeutics 2000 14 10 1319 1328
9. Gisbert J. P., Pajares R., Pajares J. M., Evolution of Helicobacter pylori therapy from a meta-analytical perspective Helicobacter 2007 12 2 50 58 (Pubitemid 350076232)
10. Graham D. Y., Fischbach L., Helicobacter pylori treatment in the era of increasing antibiotic resistance Gut 2010 59 8 1143 1153
11. Graham D. Y., Fischbach L., Sequential therapy for Helicobacter pylori infection: ethical considerations revisited Journal of Clinical Gastroenterology 2010 44 7 523
12. O'Connor A., Gisbert J. P., McNamara D., O'Morain C., Treatment of Helicobacter pylori Infection 2010 Helicobacter 2010 15 1 46 52
13. O'Connor A., Gisbert J. P., Mcnamara D., O'Morain C., Treatment of Helicobacter pylori infection 2011 Helicobacter 2011 16 supplement 1 53 58
14. Gisbert J. P., Calvet X., Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough Alimentary Pharmacology and Therapeutics 2011 34 11-12 1255 1268
15. Gisbert J. P., McNicholl A. G., Maintenance of Helicobacter pylori eradication rates with triple therapy over 12 years in a Spanish hospital. Helicobacter. In press
16. Vakil N., Hahn B., McSorley D., Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States American Journal of Gastroenterology 1998 93 9 1432 1435 (Pubitemid 29075177)
17. Mégraud F., H pylori antibiotic resistance: prevalence, importance, and advances in testing Gut 2004 53 9 1374 1384 (Pubitemid 39120130)
18. Egan B. J., Marzio L., O'Connor H., O'Morain C., Treatment of Helicobacter pylori infection Helicobacter 2008 13 1 35 40
19. Yakoob J., Abid S., Abbas Z., Jafri S. N.W., Antibiotic susceptibility patterns of Helicobacter pylori and triple therapy in a high-prevalence area British Journal of Biomedical Science 2010 67 4 197 201
20. Gisbert J. P., Pajares J. M., Review article: Helicobacter pylori 'rescue' regimen when proton pump inhibitor-based triple therapies fail Alimentary Pharmacology and Therapeutics 2002 16 6 1047 1057 (Pubitemid 34680746)
21. Gisbert J. P., Pajares J. M., Helicobacter pylori rescue therapy after failure of two eradication treatments Helicobacter 2005 10 5 363 372 (Pubitemid 41368693)
22. Gisbert J. P., Gisbert J. L., Marcos S., Jimenez-Alonso I., Moreno-Otero R., Pajares J. M., Empirical rescue therapy after Helicobacter pylori treatment failure: a 10-year single-centre study of 500 patients Alimentary Pharmacology and Therapeutics 2008 27 4 346 354
23. Romano M., Iovene M. R., Russo M. I., Rocco A., Salerno R., Cozzolino D., Pilloni A. P., Tufano M. A., Vaira D., Nardone G., Failure of first-line eradication treatment significantly increases prevalence of antimicrobial- resistant Helicobacter pylori clinical isolates Journal of Clinical Pathology 2008 61 10 1112 1115
24. Zullo A., Hassan C., Lorenzetti R., Winn S., Morini S., A clinical practice viewpoint: to culture or not to culture Helicobacter pylori ? Digestive and Liver Disease 2003 35 5 357 361 (Pubitemid 41110864)
25. Gisbert J. P., Rescue regimens after Helicobacter pylori treatment failure World Journal of Gastroenterology 2008 14 35 5385 5402
26. Gisbert J. P., Rescue therapy after Helicobacter pylori eradication failure Gastroenterologia y Hepatologia 2011 34 2 89 99
27. Graham D. Y., Efficient identification and evaluation of effective Helicobacter pylori therapies Clinical Gastroenterology and Hepatology 2009 7 2 145 148
28. Calvet X., Gisbert J. P., Suarez D., Key points for designing and reporting Helicobacter pylori therapeutic trials: a personal view Helicobacter 2011 16 5 346 355
29. Luther J., Chey W. D., Saad R. J., A clinician's guide to salvage therapy for persistent Helicobacter pylori infection Hospital Practice 2011 39 1 133 140
30. de Boer W. A., Tytgat G. N., Regular review: treatment of Helicobacter pylori infection British Medical Journal 2000 320 7226 31 34 (Pubitemid 30173015)
31. Calvet X., Gené E., Sanfeliu I., Therapeutic strategies in Helicobacter pylori infection Medicina Clinica 2001 116 6 239
32. Megraud F., Helicobacter pylori and antibiotic resistance Gut 2007 56 11 1502 (Pubitemid 350033185)
33. Parente F., Cucino C., Bianchi Porro G., Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts Digestive and Liver Disease 2003 35 8 523 528 (Pubitemid 41070406)
34. Battaglia G., Di Mario F., Vigneri S., Vianello F., Benvenuti M. E., Donisi P. M., Stracca-Pansa V., Pasquino M., Strategy for the retreatment of failed Helicobacter pylori eradication therapy: a case series Italian Journal of Gastroenterology and Hepatology 1998 30 4 370 374 (Pubitemid 28445777)
35. Yahav J., Samra Z., Niv Y., Evans C. T., Passaro D. J., Dinari G., Shmuely H., Susceptibility-guided vs. empiric retreatment of Helicobacter pylori infection after treatment failure Digestive Diseases and Sciences 2006 51 12 2316 2321
36. Lamouliatte H., Mégraud F., Delchier J.-C., Bretagne J.-F., Courillon-Mallet A., De Korwin J.-D., Fauchre J.-L., Labigne A., Fléjou J.-F., Barthelemy P., Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies Alimentary Pharmacology and Therapeutics 2003 18 8 791 797 (Pubitemid 37323644)
37. Avidan B., Melzer E., Keller N., Bar-Meir S., The effect of culture results for Helicobacter pylori on the choice of treatment following failure of initial eradication Israel Medical Association Journal 2001 3 3 163 165 (Pubitemid 32432961)
38. Miwa H., Nacahara A., Kurosawa A., Ohkusa T., Ohkura R., Hojo M., Enomoto N., Sato N., Is antimicrobial susceptibility testing necessary before second-line treatment for Helicobacter pylori infection? Alimentary Pharmacology and Therapeutics 2003 17 12 1545 1551 (Pubitemid 36831446)
39. Isomoto H., Inoue K., Furusu H., Enjoji A., Fujimoto C., Yamakawa M., Hirakata Y., Omagari K., Mizuta Y., Murase K., Shimada S., Murata I., Kohno S., High-dose rabeprazole-amoxicillin versus rabeprazole-amoxicillin-metronidazole as second-line treatment after failure of the Japanese standard regimen for Helicobacter pylori infection Alimentary Pharmacology and Therapeutics 2003 18 1 101 107 (Pubitemid 36897986)
40. Nagahara A., Miwa H., Kawabe M., Kurosawa A., Asaoka D., Hojo M., Iijima K., Terai T., Ohkusa T., Miyazaki A., Sato N., Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen Journal of Gastroenterology 2004 39 11 1051 1055 (Pubitemid 39618787)
41. Shimoyama T., Fukuda S., Mikami T., Fukushi M., Munakata A., Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population Journal of Gastroenterology 2004 39 10 927 930 (Pubitemid 39490168)
42. Murakami K., Okimoto T., Kodama M., Sato R., Miyajima H., Ono M., Inoue K., Watanabe K., Otsu S., Fujioka T., Comparison of amoxicillin-metronidazole plus famotidine or lansoprazole for amoxicillin-clarithromycin-proton pump inhibitor treatment failures for Helicobacter pylori infection Helicobacter 2006 11 5 436 440 (Pubitemid 44352614)
43. Murakami K., Okimoto T., Kodama M., Sato R., Watanabe K., Fujioka T., Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection Journal of Clinical Gastroenterology 2008 42 2 139 142
44. Ueki N., Miyake K., Kusunoki M., Shindo T., Kawagoe T., Futagami S., Tsukui T., Inagaki H., Sakamoto C., Impact of quadruple regimen of clarithromycin added to metronidazole-containing triple therapy against Helicobacter pylori infection following clarithromycin-containing triple-therapy failure Helicobacter 2009 14 2 91 99
45. Hori K., Miwa H., Matsumoto T., Efficacy of 2-week, second-line Helicobacter pylori eradication therapy using rabeprazole, amoxicillin, and metronidazole for the Japanese population Helicobacter 2011 16 3 234 240
46. Gisbert J. P., Boixeda D., Bermejo F., Rincn M. N., Higes M. J., Arpa M. A., Arata I. G., De Argila C. M., Plaza A. G., Re-treatment after Helicobacter pylori eradication failure European Journal of Gastroenterology and Hepatology 1999 11 9 1049 1054 (Pubitemid 29520565)
47. Nagahara A., Miwa H., Ohkura R., Yamada T., Sato K., Hojo M., Sato N., Strategy for retreatment of therapeutic failure of eradication of Helicobacter pylori infection Journal of Gastroenterology and Hepatology 2001 16 6 613 618 (Pubitemid 34188834)
48. Lam S. K., Talley N. J., Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection Journal of Gastroenterology and Hepatology 1998 13 1 1 12 (Pubitemid 28137751)
49. Gisbert J. P., Calvet X., Gomollon F., Sainz R., Treatment for the eradication of Helicobacter pylori. Recommendations of the Spanish Consensus Conference Medicina Clnica 2000 114 5 185 195 (Pubitemid 30140987)
50. Baena Dez J. M., Lpez Momp C., Rams Rams F., Garca Lareo M., Hernndez Ibez M. R., Teruel Gila J., Efficacy of a multistep strategy for Helicobacter pylori eradication: quadruple therapy with omeprazole, metronidazole, tetracycline and bismuth after failure of combination of omeprazole, clarithromycin and amoxycillin Medicina Clinica 2000 115 16 617 619
51. Bilardi C., Dulbecco P., Zentilin P., Reglioni S., Iiritano E., Parodi A., Accornero L., Savarino E., Mansi C., Mamone M., Vigneri S., Savarino V., A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial Clinical Gastroenterology and Hepatology 2004 2 11 997 1002 (Pubitemid 39539749)
52. Elizalde I. R., Borda F., Jara C., Martnez A., Eficacia de dos tratamientos consecutivos en la erradicacin de Helicobacter pylori Anales del Sistema Sanitario de Navarra 1998 21 supplement 2 83 88
53. Choung R. S., Lee S. W., Jung S. W., Han W. S., Kim M. J., Jeen Y. T., Park J. J., Lee H. S., Chun H. J., Um S. H., Choi J. H., Kim C. D., Ryu H. S., Hyun J. H., Comparison of the effectiveness of quadruple salvage regimen for Helicobacter pylori infection according to the duration of treatment The Korean Journal of Gastroenterology 2006 47 2 131 135
54. Su J. C., Dong H. L., Kim N., Sook H. J., Jin W. K., Jin H. H., Young S. P., Kwang H. L., Hyun C. J., In S. S., Eradication rates of Helicobacter pylori infection with second-line treatment: non-ulcer dyspepsia compared to peptic ulcer disease Hepato-Gastroenterology 2007 54 76 1293 1296 (Pubitemid 47013957)
55. Gasbarrini A., Ojetti V., Pitocco D., Armuzzi A., Gentiloni Silveri N., Pola P., Ghirlanda G., Gasbarrini G., Efficacy of different Helicobacter pylori eradication regimens in patients affected by insulin-dependent diabetes mellitus Scandinavian Journal of Gastroenterology 2000 35 3 260 263 (Pubitemid 30217177)
56. Gisbert J. P., Gisbert J. L., Marcos S., Garca Grvalos R., Carpio D., Pajares J. M., Seven-day rescue therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole Alimentary Pharmacology and Therapeutics 1999 13 10 1311 1316 (Pubitemid 29462305)
57. Gomolln F., Ducns J. A., Ferrero M., Garca Cabezudo J., Guirao R., Simn M. A., Montoro M., Quadruple therapy is effective for eradicating Helicobacter pylori after failure of triple proton-pump inhibitor-based therapy: a detailed, prospective analysis of 21 consecutive cases Helicobacter 1999 4 4 222 225 (Pubitemid 129688362)
58. Lee J. M., Breslin N. P., Hyde D. K., Buckley M. J., O'Morain C. A., Treatment options for Helicobacter pylori infection when proton pump inhibitor-based triple therapy fails in clinical practice Alimentary Pharmacology and Therapeutics 1999 13 4 489 496 (Pubitemid 29176872)
59. Lee J. H., Cheon J. H., Park M. J., Kim N., Lee D. H., Kim J. M., Kim J. S., Jung H. C., Song I. S., The trend of eradication rates of second-line quadruple therapy containing metronidazole for Helicobacter pylori infection: an analysis of recent eight years The Korean Journal of Gastroenterology 2005 46 2 94 98
60. Marko D., Calvet X., Ducons J., Guardiola J., Tito L., Bory F., Comparison of two management strategies for Helicobacter pylori treatment: clinical study and cost-effectiveness analysis Helicobacter 2005 10 1 22 32 (Pubitemid 40269370)
61. Michopoulos S., Tsibouris P., Bouzakis H., Balta A., Vougadiotis J., Broutet N., Kralios N., Randomized study comparing omeprazole with ranitidine as anti-secretory agents combined in quadruple second-Iine Helicobacter pylori eradication regimens Alimentary Pharmacology and Therapeutics 2000 14 6 737 744 (Pubitemid 30352740)
62. Navarro-Jarabo J. M., Fernndez N., Sousa F. L., Cabrera E., Castro M., Ramrez L. M., Rivera R., Ubia E., Vera F., Méndez I., Rivas-Ruiz F., Moreno J. L., Perea-Milla E., Efficacy of rifabutin-based triple therapy as second-line treatment to eradicate Helicobacter pylori infection BMC Gastroenterology 2007 7, article 31
63. Nista E. C., Candelli M., Cremonini F., Cazzato I. A., Di Caro S., Gabrielli M., Santarelli L., Zocco M. A., Ojetti V., Carloni E., Cammarota G., Gasbarrini G., Gasbarrini A., Levofloxacin-based triple therapy vs. quadruple therapy in second-line Helicobacter pylori treatment: a randomized trial Alimentary Pharmacology and Therapeutics 2003 18 6 627 633 (Pubitemid 37186612)
64. Chung J.-W., Lee J. H., Jung H.-Y., Yun S.-C., Oh T.-H., Choi K. D., Song H. J., Lee G. H., Kim J.-H., Second-line Helicobacter pylori eradication: a randomized comparison of 1-week or 2-week bismuth-containing quadruple therapy Helicobacter 2011 16 4 289 294
65. Gomolln F., Valdepérez J., Garuz R., Fuentes J., Barrera F., Malo J., Tirado M., Simn M. A., Cost/effectiveness analysis of two strategies for Helicobacter pylori eradication: results of a prospective and randomized study in primary care setting Medicina Clinica 2000 115 1 1 6
66. Malfertheiner P., Bazzoli F., Delchier J.-C., Celiski K., Gigure M., Rivire M., Mégraud F., Helicobacter pylori eradication with a capsule containing bismuth subcitrate potassium, metronidazole, and tetracycline given with omeprazole versus clarithromycin-based triple therapy: a randomised, open-label, non-inferiority, phase 3 trial The Lancet 2011 377 9769 905 913
67. Gisbert J. P., Helicobacter pylori eradication: a new, single-capsule bismuth-containing quadruple therapy Nature Reviews Gastroenterology and Hepatology 2011 8 6 307 309
68. Croom K. F., Goa K. L., Levofloxacin: a review of its use in the treatment of bacterial infections in the united states Drugs 2003 63 24 2769 2802 (Pubitemid 38049994)
69. Saad R. J., Schoenfeld P., Hyungjin M. K., Chey W. D., Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis American Journal of Gastroenterology 2006 101 3 488 496 (Pubitemid 46894012)
70. Gisbert J. P., De La Morena F., Systematic review and meta-analysis: levofloxacin-based rescue regimens after Helicobacter pylori treatment failure Alimentary Pharmacology and Therapeutics 2006 23 1 35 44 (Pubitemid 43381164)
71. Vaira D., Ricci C., Lanzini A., Perna F., Romano A., Corinaldesi R., How to proceed in Helicobacter pylori -positive chronic gastritis refractory to first- and second-line eradication therapy Digestive Diseases 2007 25 3 203 205 (Pubitemid 350194168)
72. Garca Snchez J. E., Garca Senz N., Rodrguez Rincn M., Trujillano Martn I., Garca Snchez E., Fresnadillo Martnez M. J., Susceptibility of Helicobacter pylori to mupirocin, oxazolidionones, quinupristin/dalfopristin and new quinolones Journal of Antimicrobial Chemotherapy 2000 46 2 283 285
73. Xia H. H. X., Wong B. C. Y., Talley N. J., Lam S. K., Alternative and rescue treatment regimens for Helicobacter pylori eradication Expert Opinion on Pharmacotherapy 2002 3 9 1301 1311 (Pubitemid 34966045)
74. Zou J., Yang Z. X., Qin Z. M., Laboratory and clinical study of levofloxacin against Helicobacter pylori Zhonghua Yi Xue Za Zhi 2003 83 20 1778 1781
75. Gatta L., Zullo A., Perna F., Ricci C., De Francesco V., Tampieri A., Bernabucci V., Cavina M., Hassan C., Ierardi E., Morini S., Vaira D., A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses Alimentary Pharmacology and Therapeutics 2005 22 1 45 49 (Pubitemid 40943874)
76. Antos D., Schneider-Brachert W., Bstlein E., Hnel C., Haferland C., Buchner M., Meier E., Trump F., Stolte M., Lehn N., Bayerdrffer E., 7-Day triple therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and high-dose esomeprazole in patients with known antimicrobial sensitivity Helicobacter 2006 11 1 39 45
77. Kumala W., Rani A., Patterns of Helicobacter pylori isolate resistance to fluoroquinolones, amoxicillin, clarithromycin and metronidazoles Southeast Asian Journal of Tropical Medicine and Public Health 2006 37 5 970 974 (Pubitemid 44844000)
78. Chang W. L., Sheu B. S., Cheng H. C., Yang Y. J., Yang H. B., Wu J. J., Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan Journal of Gastroenterology and Hepatology 2009 24 7 1230 1235
79. Chisholm S. A., Owen R. J., Frequency and molecular characteristics of ciprofloxacin- and rifampicin-resistant Helicobacter pylori from gastric infections in the UK Journal of Medical Microbiology 2009 58 10 1322 1328
80. Karczewska E., Wojtas-Bonior I., Sito E., Zwoliska-Wciso M., Budak A., Primary and secondary clarithromycin, metronidazole, amoxicillin and levofloxacin resistance to Helicobacter pylori in southern Poland Pharmacological Reports 2011 63 3 799 807
81. Tanaka M., Isogai E., Isogai H., Hayashi S., Hirose K., Kimura K., Sugiyama T., Sato K., Synergic effect of quinolone antibacterial agents and proton pump inhibitors on Helicobacter pylori Journal of Antimicrobial Chemotherapy 2002 49 6 1039 1040 (Pubitemid 34692903)
82. Watanabe Y., Aoyama N., Shirasaka D., Maekawa S., Kuroda K., Miki I., Kachi M., Fukuda M., Wambura C., Tamura T., Kasuga M., Levofloxacin based triple therapy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy Digestive and Liver Disease 2003 35 10 711 715 (Pubitemid 41115421)
83. Yahav J., Shmuely H., Niv Y., Bechor J., Samra Z., In vitro activity of levofloxacin against Helicobacter pylori isolates from patients after treatment failure Diagnostic Microbiology and Infectious Disease 2006 55 1 81 83
84. Matsumoto Y., Miki I., Aoyama N., Shirasaka D., Watanabe Y., Morita Y., Toyoda M., Mitani T., Miyachi H., Tamura T., Kasuga M., Levofloxacin-versus metronidazole-based rescue therapy for H. pylori infection in Japan Digestive and Liver Disease 2005 37 11 821 825 (Pubitemid 44356109)
85. Matsumoto Y., Nobuo A., Iyuka M., A High Dosage of Levofloxacin- vs. Metronidazole-based triple theraphy as a second-line treatment after failure of Helicobacter pylori eradication with standard triple therapy in Japan Gastroentorology 2005 128 2, article T963
86. Cammarota G., Cianci R., Cannizzaro O., Cuoco L., Pirozzi G., Gasbarrini A., Armuzzi A., Zocco M. A., Santarelli L., Arancio F., Gasbarrini G., Efficacy of two one-week rabeprazole/levofloxacin-based triple therapies for Helicobacter pylori infection Alimentary Pharmacology and Therapeutics 2000 14 10 1339 1343
87. Di Caro S., Zocco M. A., Cremonini F., Candelli M., Nista E. C., Bartolozzi F., Armuzzi A., Cammarota G., Santarelli L., Gasbarrini A., Levofloxacin based regimens for the eradication of Helicobacter pylori European Journal of Gastroenterology and Hepatology 2002 14 12 1309 1312 (Pubitemid 36054918)
88. Marzio L., Coraggio D., Capodicasa S., Grossi L., Cappello G., Role of the preliminary susceptibility testing for initial and after failed therapy of Helicobacter pylori infection with levofloxacin, amoxicillin, and esomeprazole Helicobacter 2006 11 4 237 242 (Pubitemid 44051349)
89. Rispo A., Di Girolamo E., Cozzolino A., Bozzi R., Morante A., Pasquale L., Levofloxacin in first-line treatment of Helicobacter pylori infection Helicobacter 2007 12 4 364 365 (Pubitemid 47196341)
90. Gisbert J. P., Fernndez-Bermejo M., Molina-Infante J., Pérez-Gallardo B., Prieto-Bermejo A.-B., Mateos-Rodrguez J.-M., Robledo-Andrés P., Gonzlez-Garca G., First-line triple therapy with levofloxacin for Helicobacter pylori eradication Alimentary Pharmacology and Therapeutics 2007 26 3 495 500 (Pubitemid 47063147)
91. Lee J. H., Hong S. P., Kwon C. I., Phyun L. H., Lee B. S., Song H. U., Ko K. H., Hwang S. G., Park P. W., Rim K. S., Kim S., The efficacy of levofloxacin based triple therapy for Helicobacter pylori eradication The Korean Journal of Gastroenterology 2006 48 1 19 24
92. Perri F., Festa V., Merla A., Barberani F., Pilotto A., Andriulli A., Randomized study of different second-line therapies for Helicobacter pylori infection after failure of the standard Maastricht triple therapy Alimentary Pharmacology and Therapeutics 2003 18 8 815 820 (Pubitemid 37323647)
93. Orsi P., Pinazzi O., Aragona G., Di Mario F., Rabeprazole/Levofloxacin based triple therapy as a Salvatage Treatment after Failure of H. pylori eradication with standard regimens Helicobacter 2003 8 339 493
94. Wong W. M., Gu O., Lam S. K., Fung F. M. Y., Lai K. C., Hu W. H. C., Yee Y. K., Chan C. K., Xia H. H. X., Yuen M. F., Wong B. C. Y., Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection Alimentary Pharmacology and Therapeutics 2003 17 4 553 560 (Pubitemid 36384814)
95. Wong W. M., Gu Q., Chu K. M., Yee Y. K., Fung F. M. Y., Tong T. S. M., Chan A. O. O., Lai K. C., Chan C. K., Wong B. C. Y., Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection Alimentary Pharmacology and Therapeutics 2006 23 3 421 427 (Pubitemid 43382022)
96. Gisbert J. P., Bermejo F., Castro-Fernndez M., Pérez-Aisa A., Fernndez-Bermejo M., Tomas A., Barrio J., Bory F., Almela P., Snchez-Pobre P., Cosme A., Ortiz V., Nio P., Khorrami S., Benito L.-M., Carneros J.-A., Lamas E., Modolell I., Franco A., Ortuo J., Rodrigo L., Garca-Durn F., O'Callaghan E., Ponce J., Valer M.-P., Calvet X., Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients American Journal of Gastroenterology 2008 103 1 71 76
97. Giannini E. G., Bilardi C., Dulbecco P., Mamone M., Santi M. L., Testa R., Mansi C., Savarino V., A study of 4- and 7-day triple therapy with rabeprazole, high-dose levofloxacin and tinidazole rescue treatment for Helicobacter pylori eradication Alimentary Pharmacology and Therapeutics 2006 23 2 281 287 (Pubitemid 43382038)
98. Page R. L., Ferguson D., Cantu M., An alternative salvage regimen for Helicobacter pylori -resistant patients with heart failure Cardiology 2008 110 2 112 115 (Pubitemid 351630036)
99. Lee Y. C., Wu H. M., Chen T. H. H., Liu T. Y., Chiu H. M., Chang C. C., Wang H. P., Wu M. S., Chiang H., Wu M. C., Lin J. T., A community-based study of Helicobacter pylori therapy using the strategy of test, treat, retest, and re-treat initial treatment failures Helicobacter 2006 11 5 418 424 (Pubitemid 44352611)
100. Di Caro S., Franceschi F., Mariani A., Thompson F., Raimondo D., Masci E., Testoni A., La Rocca E., Gasbarrini A., Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication Digestive and Liver Disease 2009 41 7 480 485
101. Eisig J. N., Silva F. M., Barbuti R. C., Rodriguez T. N., Malfertheiner P., Filho M. J.P.P., Zaterka S., Efficacy of a 7-day course of furazolidone, levofloxacin, and lansoprazole after failed Helicobacter pylori eradication BMC Gastroenterology 2009 9, article 38
102. Kuo C.-H., Hu H.-M., Kuo F.-C., Hsu P.-I., Chen A., Yu F.-J., Tsai P.-Y., Wu I.-C., Wang S.-W., Li C.-J., Weng B.-C., Chang L.-L., Jan C.-M., Wang W.-M., Wu D.-C., Efficacy of levofloxacin-based rescue therapy for Helicobacter pylori infection after standard triple therapy: a randomized controlled trial Journal of Antimicrobial Chemotherapy 2009 63 5 1017 1024
103. Schrauwen R. W. M., Janssen M. J. R., de Boer W. A., Seven-day PPI-triple therapy with levofloxacin is very effective for Helicobacter pylori eradication Netherlands Journal of Medicine 2009 67 3 96 101
104. Chen L. W., Chien R. N., Chang J. J., Fang K. M., Chang L. C., Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study International Journal of Clinical Practice 2010 64 11 1530 1534
105. Erin C. N., Uygun A., Toros A. B., Kantarciolu M., Kilciler G., Polat Z., Baci S., Comparison of 7- and 14-day first-line therapies including levofloxacin in patients with Helicobacter pylori positive non-ulcer dyspepsia Turkish Journal of Gastroenterology 2010 21 1 12 16
106. Li Y., Huang X., Yao L., Shi R., Zhang G., Advantages of Moxifloxacin and Levofloxacin-based triple therapy for second-line treatments of persistent Helicobacter pylori infection: a meta analysis Wiener Klinische Wochenschrift 2010 122 13-14 413 422
107. Kahn J. B., Latest industry information on the safety profile of levofloxacin in the US Chemotherapy 2001 47 supplement 3 32 37 (Pubitemid 32823914)
108. Cabrita J., Oleastro M., Matos R., Manhente A., Cabralc J., Barros R., Lopes A. I., Ramalho P., Neves B. C., Guerreiro A. S., Features and trends in Helicobacter pylori antibiotic resistance in Lisbon area, Portugal (19901999) Journal of Antimicrobial Chemotherapy 2000 46 6 1029 1031 (Pubitemid 32000618)
109. Cammarota G., Cianci R., Cannizzaro O., Martino A., Fedeli P., Lecca P. G., Di Caro S., Cesaro P., Branca G., Gasbarrini G., High-dose versus low-dose clarithromycin in 1-week triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication Journal of Clinical Gastroenterology 2004 38 2 110 114 (Pubitemid 38134147)
110. Coelho L. G.V., Moretzsohn L. D., Vieira W. L.S., Gallo M. A., Passos M. C.F., Cindr J. M., Cerqueira M. C., Vitiello L., Ribeiro M. L., Mendona S., Pedrazzoli-Jnior J., Castro L. P., New once-daily, highly effective rescue triple therapy after multiple Helicobacter pylori treatment failures: a pilot study Alimentary Pharmacology and Therapeutics 2005 21 6 783 787 (Pubitemid 40469006)
111. Bogaerts P., Berhin C., Nizet H., Glupczynski Y., Prevalence and mechanisms of resistance to fluoroquinolones in Helicobacter pylori strains from patients living in Belgium Helicobacter 2006 11 5 441 445 (Pubitemid 44352615)
112. Kim J. M., Antibiotic resistance of Helicobacter pylori isolated from Korean patients The Korean Journal of Gastroenterology 2006 47 5 337 349
113. Kim J. M., Kim J. S., Kim N., Kim S. G., Jung H. C., Song I. S., Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patients International Journal of Antimicrobial Agents 2006 28 1 6 13
114. Miyachi H., Miki I., Aoyama N., Shirasaka D., Matsumoto Y., Toyoda M., Mitani T., Morita Y., Tamura T., Kinoshita S., Okano Y., Kumagai S., Kasuga M., Primary levofloxacin resistance and gyrA/B mutations among Helicobacter pylori in Japan Helicobacter 2006 11 4 243 249 (Pubitemid 44051350)
115. Carothers J. J., Bruce M. G., Hennessy T. W., Bensler M., Morris J. M., Reasonover A. L., Hurlburt D. A., Parkinson A. J., Coleman J. M., McMahon B. J., The relationship between previous fluoroquinolone use and levofloxacin resistance in Helicobacter pylori infection Clinical Infectious Diseases 2007 44 2 e5 e8
116. Cattoir V., Nectoux J., Lascols C., Deforges L., Delchier J. C., Megraud F., Soussy C. J., Cambau E., Update on fluoroquinolone resistance in Helicobacter pylori: new mutations leading to resistance and first description of a gyrA polymorphism associated with hypersusceptibility International Journal of Antimicrobial Agents 2007 29 4 389 396 (Pubitemid 46357606)
117. Glocker E., Stueger H.-P., Kist M., Quinolone resistance in Helicobacter pylori isolates in Germany Antimicrobial Agents and Chemotherapy 2007 51 1 346 349 (Pubitemid 46047727)
118. Perna F., Zullo A., Ricci C., Hassan C., Morini S., Vaira D., Levofloxacin-based triple therapy for Helicobacter pylori re-treatment: role of bacterial resistance Digestive and Liver Disease 2007 39 11 1001 1005 (Pubitemid 350018698)
119. Zullo A., Perna F., Hassan C., Ricci C., Saracino I., Morini S., Vaira D., Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy Alimentary Pharmacology and Therapeutics 2007 25 12 1429 1434 (Pubitemid 46848887)
120. Gao W., Cheng H., Hu F., Li J., Wang L., Yang G., Xu L., Zheng X., The evolution of Helicobacter pylori antibiotics resistance over 10 years in Beijing, China Helicobacter 2010 15 5 460 466
121. Raymond J., Lamarque D., Kalach N., Chaussade S., Burucoa C., High level of antimicrobial resistance in French Helicobacter pylori isolates Helicobacter 2010 15 1 21 27
122. Hung K. H., Sheu B. S., Chang W. L., Wu H. M., Liu C. C., Wu J. J., Prevalence of primary fluoroquinolone resistance among clinical isolates of Helicobacter pylori at a University Hospital in Southern Taiwan Helicobacter 2009 14 1 61 65
123. Boyanova L., Mitov I., Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents Expert Review of Anti-Infective Therapy 2010 8 1 59 70
124. Ermis F., Akyuz F., Uyanikoglu A., Kurt R., Pinarbasi B., Nazik H., Kaymakoglu S., Mungan Z., Second-line levofloxacin-based triple therapy's efficiency for Helicobacter pylori eradication in patients with peptic ulcer Southern Medical Journal 2011 104 8 579 583
125. Yamade M., Sugimoto M., Uotani T., Nishino M., Kodaira C., Furuta T., Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan Journal of Gastroenterology and Hepatology 2011 26 9 1457 1461
126. Krakowka S., Ringler S. S., Eaton K. A., Green W. B., Leunk R.,
127. Lee J. W., Kim N., Nam R. H., Park J. H., Kim J. M., Jung H. C., Song I. S., Mutations of Helicobacter pylori associated with fluoroquinolone resistance in Korea Helicobacter 2011 16 4 301 310
128. Zullo A., de Francesco V., Manes G., Scaccianoce G., Cristofari F., Hassan C., Second-line and rescue therapies for Helicobacter pylori eradication in clinical practice Journal of Gastrointestinal and Liver Diseases 2010 19 2 131 134
129. Reilly T. G., Ayres R. C.S., Poxon V., Walt R. P., Helicobacter pylori eradication in a clinical setting: success rates and the effect on the quality of life in peptic ulcer Alimentary Pharmacology and Therapeutics 1995 9 5 483 490
130. Lerang F., Moum B., Haug J. B., Berge T., Tols P., Sandvei P. K., Torp R., Tnnesen T., Highly effective second-line anti- Helicobacter pylori therapy in patients with previously failed metronidazole-based therapy Scandinavian Journal of Gastroenterology 1997 32 12 1209 1214 (Pubitemid 28023124)
131. Magaret N., Burm M., Faigel D., Kelly C., Peterson W., Fennerty M. B., A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy Digestive Diseases 2001 19 2 174 178 (Pubitemid 32823931)
132. Deltenre M., Ntounda R., Jonas C., De Koster E., Eradication of Helicobacter pylori: why does it fail? Italian Journal of Gastroenterology and Hepatology 1998 30 supplement 3 S326 S328
133. Axon A. T. R., Treatment of Helicobacter pylori: an overview Alimentary Pharmacology and Therapeutics 2000 14 3 1 6
134. Peitz U., Hackelsberger A., Malfertheiner P., A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy Drugs 1999 57 6 905 920 (Pubitemid 29313202)
135. Peitz U., Sulliga M., Wolle K., Leodolter A., Von Arnim U., Kahl S., Stolte M., Brsch G., Labenz J., Malfertheiner P., High rate of post-therapeutic resistance after failure of macrolide-nitroimidazole triple therapy to cure Helicobacter pylori infection: impact of two second-line therapies in a randomized study Alimentary Pharmacology and Therapeutics 2002 16 2 315 324 (Pubitemid 34146373)
136. Beales I. L. P., Efficacy of Helicobacter pylori eradication therapies: a single centre observational study BMC Gastroenterology 2001 1, article 7
137. Miehlke S., Hansky K., Schneider-Brachert W., Kirsch C., Morgner A., Madisch A., Kuhlisch E., Bstlein E., Jacobs E., Bayerdrffer E., Lehn N., Stolte M., Randomized trial of rifabutin-based triple therapy and high-dose dual therapy for rescue treatment of Helicobacter pylori resistant to both metronidazole and clarithromycin Alimentary Pharmacology and Therapeutics 2006 24 2 395 403 (Pubitemid 43972908)
138. Gisbert J. P., Mur M., Sainz S., Cea G., Martn C., Sainz R., Boixeda D., Monés J., Is the combination omeprazole plus amoxycillin useful in eradicating Helicobacter playori in Spain? Revista Espanola de Enfermedades Digestivas 1996 88 2 99 106
139. Houben M. H. M. G., Van De Beek D., Hensen E. F., De Craen A. J. M., Rauws E. A. J., Tytgat G. N. J., A systematic review of Helicobacter pylori eradication therapythe impact of antimicrobial resistance on eradication rates Alimentary Pharmacology and Therapeutics 1999 13 8 1047 1055 (Pubitemid 29374105)
140. Dore M. P., Leandro G., Realdi G., Sepulveda A. R., Graham D. Y., Effect of pretreatment antibiotic resistance to metronidazole and clarithromycin on outcome of Helicobacter pylori therapy: a meta-analytical approach Digestive Diseases and Sciences 2000 45 1 68 76 (Pubitemid 30111690)
141. Van Der Wouden E. J., Thijs J. C., Van Zwet A. A., Sluiter W. J., Kleibeuker J. H., The influence of in vitro nitroimidazole resistance on the efficacy of nitroimidazole-containing anti- Helicobacter pylori regimens: a meta-analysis American Journal of Gastroenterology 1999 94 7 1751 1759 (Pubitemid 29315882)
142. Tompkins D. S., Perkin J., Smith C., Failed treatment of Helicobacter pylori infection associated with resistance to clarithromycin Helicobacter 1997 2 4 185 187 (Pubitemid 127686209)
143. Pilotto A., Franceschi M., Rassu M., Leandro G., Bozzola L., Furlan F., Di Mario F., Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study Digestive and Liver Disease 2000 32 8 667 672
144. Saad R. J., Chey W. D., Persistent Helicobacter pylori infection after a course of antimicrobial therapy-what's next? Clinical Gastroenterology and Hepatology 2008 6 10 1086 1090
145. De Boer W., Driessen W., Jansz A., Tytgat G., Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection The Lancet 1995 345 8953 806 820
146. Sun Q., Liang X., Zheng Q., Liu W., Xiao S., Gu W., Lu H., High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication Helicobacter 2010 15 3 233 238
147. Minakari M., Davarpanah Jazi A. H., Shavakhi A., Moghareabed N., Fatahi F., A randomized controlled trial: efficacy and safety of azithromycin, ofloxacin, bismuth, and omeprazole compared with amoxicillin, clarithromycin, bismuth, and omeprazole as second-line therapy in patients with Helicobacter pylori infection Helicobacter 2010 15 2 154 159
148. Cudia B., Romano M., Gio F. P., Barbera N., Lo Gerfo D., Montalto R., Rescue therapy including ranitidine bismuth citrate + minocicline + amoxicillin for eradication of Helicobacter pylori in previous H.P. treatment failure Gut 1997 41 supplement 1, article A103
149. Gisbert J. P., Calvet X., Review article: rifabutin in the treatment of refractory Helicobacter pylori infection Alimentary Pharmacology and Therapeutics 2012 35 2 209 221
150. Zullo A., De Francesco V., Hassan C., Panella C., Morini S., Ierardi E., Second-line treatment for Helicobacter pylori eradication after sequential therapy failure: a pilot study Therapy 2006 3 2 251 254
151. Rokkas T., Sechopoulos P., Robotis I., Margantinis G., Pistiolas D., Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the maastricht III consensus and a third-line empirical regimen American Journal of Gastroenterology 2009 104 1 21 25
152. Gisbert J. P., Attitude in Helicobacter pylori eradication therapy failure: surrender or combat? Medicina Clinica 1998 111 20 778 782 (Pubitemid 29019246)
153. Lee B. H., Kim N., Hwang T. J., Lee S. H., Park Y. S., Hwang J. H., Kim J. W., Jeong S. H., Lee D. H., Jung H. C., Song I. S., Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea Helicobacter 2010 15 1 38 45
154. Perri F., Festa V., Clemente R., Villani M. R., Quitadamo M., Caruso N., Li Bergoli M., Andriulli A., Randomized study of two rescue therapies for Helicobacter pylori -infected patients after failure of standard triple therapies American Journal of Gastroenterology 2001 96 1 58 62 (Pubitemid 32104808)
155. Sicilia B., Sierra E., Lago A., Villar M., Garca S., Gomolln F., High eradication rates in Helicobacter pylori infection in patients with duodenal ulcer who failed previous eradication therapy Medicina Clinica 2000 115 17 641 643 (Pubitemid 32059455)
156. Usta Y., Saltik-Temizel I. N., Demir H., Uslu N., Ozen H., Gurakan F., Yuce A., Comparison of short- and long-term treatment protocols and the results of second-line quadruple therapy in children with Helicobacter pylori infection Journal of Gastroenterology 2008 43 6 429 433 (Pubitemid 351997879)
157. Uygun A., Ozel A. M., Yildiz O., Aslan M., Yesilova Z., Erdil A., Bagci S., Gunhan O., Comparison of three different second-line quadruple therapies including bismuth subcitrate in Turkish patients with non-ulcer dyspepsia who failed to eradicate Helicobacter pylori with a 14-day standard first-line therapy Journal of Gastroenterology and Hepatology 2008 23 1 42 45 (Pubitemid 350265196)
158. Wu D. C., Hsu P. I., Chen A., Lai K. H., Tsay F. W., Wu C. J., Lo G. H., Wu J. Y., Wu I. C., Wang W. M., Tseng H. H., Randomized comparison of two rescue therapies for Helicobacter pylori infection European Journal of Clinical Investigation 2006 36 11 803 809 (Pubitemid 44569969)
159. Wu D.-C., Hsu P.-I., Tseng H.-H., Tsay F.-W., Lai K.-H., Kuo C.-H., Wang S.-W., Chen A., Helicobacter pylori infection: a randomized, controlled study comparing 2 rescue therapies after failure of standard triple therapies Medicine 2011 90 3 180 185